OCUL
Ocular Therapeutix (OCUL)
$39
About Ocular Therapeutix (OCUL)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
Details
Daily high
$14.53
Daily low
$14.12
Price at open
$14.12
52 Week High
$16.44
52 Week Low
$5.78
Market cap
3.0B
Dividend yield
0.00%
Volume
3.1M
Avg. volume
3.8M
P/E ratio
-9.86
Ocular Therapeutix News
Details
Daily high
$14.53
Daily low
$14.12
Price at open
$14.12
52 Week High
$16.44
52 Week Low
$5.78
Market cap
3.0B
Dividend yield
0.00%
Volume
3.1M
Avg. volume
3.8M
P/E ratio
-9.86